Quarterly Outlook
Equity outlook: The high cost of global fragmentation for US portfolios
Charu Chanana
Chief Investment Strategist
You can access all of our platforms from a single Saxo account.
Technical Update - Novo Nordisk: Stretched uptrend could continue higher
Equities 3 minutes to read
Kim Cramer Larsson
Technical Analyst, Saxo Bank
Summary: Novo Nordisk short-, medium- and longer-term technical outlook
Novo Nordisk delivered blow out earnings this morning pre-market.
The uptrend seems to continue.
If Novo is closing around current levels and the RSI is closing back above the 60 threshold i.e., back in positive sentiment, Novo share price is likely to move to test all-time highs at around 742.20
To reverse the short-term uptrend a close below 655.40 is needed.
Medium-term – weekly chart: RSI values have been declining for almost 2 years indicating a stretched uptrend. However, if the uptrend is intact and a close below 614 is needed to demolish that.
If Novo is performing a new higher close above 742.20 the RSI divergence could be cancelled thus strongly indicating the uptrend is to continue
If Novo is performing a new higher close above 742.20 the RSI divergence could be cancelled thus strongly indicating the uptrend is to continue
Longer-term - monthly chart: RSI divergence is close to be traded out. That situation occurs if RSI is closing above 87.61 which is quite close. If that scenario plays out the could be further upside potential for Novo.
However, the monthly RSI is in overbought territory and traded volume has been declining for several years indicating a looming (big) correction. However, a top and reversal pattern is not yet formed adn to reverse the longer term uptrdn a clsoe below 504.40 is needed.
However, the monthly RSI is in overbought territory and traded volume has been declining for several years indicating a looming (big) correction. However, a top and reversal pattern is not yet formed adn to reverse the longer term uptrdn a clsoe below 504.40 is needed.
Author is holding a position in Novo Nordisk
Latest Market Insights
Quarterly Outlook
-
-
Quarterly Outlook
Commodity Outlook: Commodities rally despite global uncertainty
Ole Hansen
Head of Commodity Strategy
-
Quarterly Outlook
Upending the global order at blinding speed
John J. Hardy
Global Head of Macro Strategy
We are witnessing a once-in-a-lifetime shredding of the global order. As the new order takes shape, ... -
Quarterly Outlook
Asset allocation outlook: From Magnificent 7 to Magnificent 2,645—diversification matters, now more than ever
Jacob Falkencrone
Global Head of Investment Strategy
-
Quarterly Outlook
Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?
John J. Hardy
Global Head of Macro Strategy
-
Quarterly Outlook
Equity Outlook: The ride just got rougher
Charu Chanana
Chief Investment Strategist
-
Quarterly Outlook
China Outlook: The choice between retaliation or de-escalation
Charu Chanana
Chief Investment Strategist
-
Quarterly Outlook
Commodity Outlook: A bumpy road ahead calls for diversification
Ole Hansen
Head of Commodity Strategy
-
Quarterly Outlook
FX outlook: Tariffs drive USD strength, until...?
John J. Hardy
Global Head of Macro Strategy
-
Quarterly Outlook
Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges
Althea Spinozzi
Head of Fixed Income Strategy